Related Experiment Video
Updated: Jul 4, 2026
08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
A sandwich ELISA for phosphoglycerate kinase
Weilin Zhao1, Seinyone Pao, Fatima Malik
1Department of Anatomy and Cell Biology, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA.
Journal of Immunoassay & Immunochemistry
|June 24, 2008
Summary
Researchers developed a sensitive assay to measure phosphoglycerate kinase (PGK1) levels. Elevated PGK1 in serum may indicate pancreatic cancer, offering a potential new screening tool.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Phosphoglycerate kinase (PGK1) is a glycolytic enzyme with extracellular functions.
- Extracellular PGK1 activates plasmin, leading to angiostatin production, an angiogenesis inhibitor.
- Certain cancers secrete elevated PGK1, suggesting its potential as a cancer biomarker.
Purpose of the Study:
- To develop a sensitive assay for quantifying phosphoglycerate kinase (PGK1).
- To investigate the PGK1 secretory pathway.
- To assess serum PGK1 levels as a potential cancer screening biomarker.
Main Methods:
- Development of a sensitive sandwich ELISA using immuno-affinity-purified chicken and rabbit polyclonal antibodies.
- Quantification of PGK1 released from HeLa cells.
- Measurement of serum PGK1 levels in cancer patients.
Main Results:
- The developed ELISA is approximately 10-fold more sensitive than existing PGK1 assays.
- Quantified PGK1 release from HeLa cells.
- Observed significantly higher serum PGK1 levels (65-900%) in 3 out of 4 pancreatic cancer patients compared to normal serum.
Conclusions:
- The novel ELISA is a sensitive tool for PGK1 detection and characterization.
- Elevated serum PGK1 levels show promise as a biomarker for pancreatic cancer detection.
- Further research is warranted to validate PGK1 as a clinical cancer biomarker.
